Jasper Therapeutics, Inc.

JSPR

$0.67

-2.29%

N/A-$0.02

Healthcare

Biotechnology

NASDAQ

Active Trading

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company’s lead ...

Insider Transactions of JSPR

Acquisitions (A)

Since Jul 16, 2026

Disposals (D)

Since Jul 16, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jul 31, 2026	WIGGANS THOMAS G	director	Stock Option (Right to Buy	A	7,500	$0.63
Jul 31, 2026	Lucas Svetlana	director	Stock Option (Right to Buy	A	7,500	$0.63
Jul 31, 2026	Crutcher Patrick J	director	Stock Option (Right to Buy	A	7,500	$0.63
Jul 31, 2026	EMSTER KURT VON	director	Stock Option (Right to Buy	A	7,500	$0.63
Jul 31, 2026	Shizuru Judith Anne	director	Stock Option (Right to Buy	A	7,500	$0.63

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

39,269

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Crutcher Patrick J

director • 2 txns

Keenan Greg

officer: Chief Medical Officer • 2 txns

WIGGANS THOMAS G

director • 1 txns

Lucas Svetlana

director • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jul 31, 2026	WIGGANS THOMAS G	director	Stock Option (Right to Buy	A	7,500	$0.63	$4,725.00
Jul 31, 2026	Lucas Svetlana	director	Stock Option (Right to Buy	A	7,500	$0.63	$4,725.00
Jul 31, 2026	Crutcher Patrick J	director	Stock Option (Right to Buy	A	7,500	$0.63	$4,725.00
Jul 31, 2026	EMSTER KURT VON	director	Stock Option (Right to Buy	A	7,500	$0.63	$4,725.00
Jul 31, 2026	Shizuru Judith Anne	director	Stock Option (Right to Buy	A	7,500	$0.63	$4,725.00
Jul 20, 2026	Ros Matthew E	officer: Chief Operating Officer	Non-Voting Convertible Preferred Stock	A	881	—	—
Jul 20, 2026	Crutcher Patrick J	director	Non-Voting Convertible Preferred Stock	A	888	—	—
Jul 16, 2026	Keenan Greg	officer: Chief Medical Officer	Stock Option (Right to Buy)	—	103,204	$0.01	$1,032.04
Jul 16, 2026	Keenan Greg	officer: Chief Medical Officer	Stock Option (Right to Buy)	—	92,278	$0.61	$56,289.58
Jul 16, 2026	Song Wenru	officer: EVP, Head of R&D	Voting Common Stock	—	0	—	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer